[Stanford Doctor Explores Business Value Investment 01]

In this episode, we have invited three special guests to explore the close connection between sports, economy, and culture. This discussion uses football as a starting point, covering topics from Luneng Taishan's youth training to China's national sports system; from Messi's legendary career to unforgettable World Cup moments; from the evolution of modern football tactics to the nurturing of future stars. We also delve into the business models of football, the impact of VAR technology, comparisons of the top five European leagues, and the intertwining of football with different cultures. 

「You Will Hear」

（Episode 01）

02:15 - Discussion on Messi's career highlights and his performance at different clubs 

07:30 - Recap of the most memorable moments in World Cup history 

12:45 - Analysis of the development and impact of modern football tactics

17:10 - Discussion on the training of young players and the potential of future football stars 

23:05 - Discussion on the business models and economic impact of football clubs

 29:40 - Evaluation of the impact and controversies of VAR technology on matches 

34:55 - Comparison of the styles and competitiveness of the top five European leagues

41:20 - Discussion on the intertwining of football and culture, and the characteristics of football cultures in different countries.

「Host」

Speaker1: David is a seasoned sports enthusiast and an adventurous business visionary. His travels span over thirty countries across Europe, the U.S., and Australia, where he has accumulated extensive business development experience and entrepreneurial wisdom on the global stage. David's career is a kaleidoscope of achievements: he was a pioneer at tech giant Apple, expanded into new territories overseas, and even became a professional poker player with a keen insight into human nature. These cross-industry experiences have not only endowed him with a "poker face" but also sharpened his business intuition and risk management skills.

「Guest」

Speaker2: Lau is a former sports industry professional with a diverse career background. He previously handled investment and financing at two prominent domestic internet sports companies, offering him unique insights into the sports industry. Later, Lau transitioned into various roles in state-owned enterprises, government, and urban investment platforms, accumulating extensive industry experience and life philosophy.

Speaker3: Preston is a versatile professional with a rich educational background and unique career experiences. He graduated from medical school with a degree in medicine, acquiring solid medical knowledge and practical experience. During his medical studies, Preston not only learned medical skills but also developed a deep understanding and empathy for human health. After completing his studies, Preston chose to become a military doctor, serving the country. His military experience exposed him to various complex medical challenges and enhanced his emergency response and team collaboration skills. Today, Preston is a distinguished financial journalist known for his rigorous professional attitude and keen insight.

「Music」

「Find Us Here」

[Stanford Doctor's Technology Entrepreneurship 03]

As technical founders in the American biotech industry, Dr. Che and Dr. Janice frequently participate in various industry conferences and professional exchanges. Their extensive knowledge, keen insights, and hands-on experience will bring listeners high-quality information and unique perspectives that are rare domestically. This dialogue will not only showcase how AI technology drives innovation and breakthroughs in the field of biotechnology but also explore the profound impact of this revolutionary change on the entire healthcare industry.

"What You'll Hear"

01:00 Applications of AI technology in the pharmaceutical industry and the driving forces behind it

06:10 How to express complex content in a simple way?

08:11 A step in GPT training: transforming structured language into a language that natural language systems can understand

10:12 The future of AI: why programming and model training are so important?

12:12 AI and LIFES: key trends and opportunities for the next decade

14:14 AI and LIFESS: challenges and opportunities, exploring the possibility of human-machine coexistence

18:15 Applications and challenges of AI technology in drug development—Dr. Che Xing's perspectives and insights

"Permanent Hosts"

"Special Guest"

Dr. Janice graduated from Stanford University and has nearly 15 years of study and work experience in the United States. Her academic accomplishments are impressive, with multiple top-tier academic papers and several international patents. Driven by a passion for biotechnology, Dr. Janice founded N1 Life in Silicon Valley. This innovative company focuses on developing cutting-edge drug delivery technologies, skillfully combining the latest molecular and computational technologies to design and develop new drug delivery vectors, aiming to empower the entire drug development industry.

Under Dr. Janice's leadership, N1 Life has garnered extensive support from Stanford University and has had the fortune to invite a member of the National Academy of Sciences as a co-founder, highlighting the company’s strong academic background and technical prowess.

Dr. Che, founded YDS Pharmatech in New York State, a company at the forefront of integrating AI with biotechnology. YDS Pharmatech focuses on applying the latest AI technology to a computational design platform for multi-specific drugs.

Under Dr. Che's leadership, the company has made significant achievements in AI-enhanced biophysical simulations, with related research published in top journals like Nature Chemical Biology. YDS Pharmatech's influence extends far beyond its origins. The company has launched several global collaborative projects, with business spanning the U.S. from New York to Boston to California, and further expanding to China, Japan, and South Korea. Currently, YDS Pharmatech has established close collaborations with multiple biotech and biopharmaceutical companies, including large enterprises like Mitsubishi Tanabe Pharma, and several emerging companies invested by prominent venture capital firms such as RA Capital and Atlas Ventures.

"Music"

"Find Us Here"

[Stanford Doctor's Technology Entrepreneurship 02]

As technical founders in the American biotech industry, Dr. Che and Dr. Janice frequently participate in various industry conferences and professional exchanges. Their extensive knowledge, keen insights, and hands-on experience will bring listeners high-quality information and unique perspectives that are rare domestically. This dialogue will not only showcase how AI technology drives innovation and breakthroughs in the field of biotechnology but also explore the profound impact of this revolutionary change on the entire healthcare industry.

"What You'll Hear"

07:17 Current top companies and technologies in the AI + biopharmaceutical field

24:17 Different growth paths of AI companies developing biotech and Biotech companies extending AI technology

30:06 Challenges and opportunities: difficulties and future prospects in the development of AI technology

33:51 Interdisciplinary communication and talent cultivation in the AI + biopharmaceutical field

"Permanent Hosts"

"Special Guest"

Dr. Janice graduated from Stanford University and has nearly 15 years of study and work experience in the United States. Her academic accomplishments are impressive, with multiple top-tier academic papers and several international patents. Driven by a passion for biotechnology, Dr. Janice founded N1 Life in Silicon Valley. This innovative company focuses on developing cutting-edge drug delivery technologies, skillfully combining the latest molecular and computational technologies to design and develop new drug delivery vectors, aiming to empower the entire drug development industry.

Under Dr. Janice's leadership, N1 Life has garnered extensive support from Stanford University and has had the fortune to invite a member of the National Academy of Sciences as a co-founder, highlighting the company’s strong academic background and technical prowess.

Dr. Che, founded YDS Pharmatech in New York State, a company at the forefront of integrating AI with biotechnology. YDS Pharmatech focuses on applying the latest AI technology to a computational design platform for multi-specific drugs.

Under Dr. Che's leadership, the company has made significant achievements in AI-enhanced biophysical simulations, with related research published in top journals like Nature Chemical Biology. YDS Pharmatech's influence extends far beyond its origins. The company has launched several global collaborative projects, with business spanning the U.S. from New York to Boston to California, and further expanding to China, Japan, and South Korea. Currently, YDS Pharmatech has established close collaborations with multiple biotech and biopharmaceutical companies, including large enterprises like Mitsubishi Tanabe Pharma, and several emerging companies invested by prominent venture capital firms such as RA Capital and Atlas Ventures.

"Music"

"Find Us Here"

[Stanford Doctor's Technology Entrepreneurship 01]

As technical founders in the American biotech industry, Dr. Che and Dr. Janice frequently participate in various industry conferences and professional exchanges. Their extensive knowledge, keen insights, and hands-on experience will bring listeners high-quality information and unique perspectives that are rare domestically. This dialogue will not only showcase how AI technology drives innovation and breakthroughs in the field of biotechnology but also explore the profound impact of this revolutionary change on the entire healthcare industry.

"What You'll Hear"

"Permanent Hosts"

"Special Guest"

Dr. Janice graduated from Stanford University and has nearly 15 years of study and work experience in the United States. Her academic accomplishments are impressive, with multiple top-tier academic papers and several international patents. Driven by a passion for biotechnology, Dr. Janice founded N1 Life in Silicon Valley. This innovative company focuses on developing cutting-edge drug delivery technologies, skillfully combining the latest molecular and computational technologies to design and develop new drug delivery vectors, aiming to empower the entire drug development industry.

Under Dr. Janice's leadership, N1 Life has garnered extensive support from Stanford University and has had the fortune to invite a member of the National Academy of Sciences as a co-founder, highlighting the company’s strong academic background and technical prowess.

Dr. Che, founded YDS Pharmatech in New York State, a company at the forefront of integrating AI with biotechnology. YDS Pharmatech focuses on applying the latest AI technology to a computational design platform for multi-specific drugs.

Under Dr. Che's leadership, the company has made significant achievements in AI-enhanced biophysical simulations, with related research published in top journals like Nature Chemical Biology. YDS Pharmatech's influence extends far beyond its origins. The company has launched several global collaborative projects, with business spanning the U.S. from New York to Boston to California, and further expanding to China, Japan, and South Korea. Currently, YDS Pharmatech has established close collaborations with multiple biotech and biopharmaceutical companies, including large enterprises like Mitsubishi Tanabe Pharma, and several emerging companies invested by prominent venture capital firms such as RA Capital and Atlas Ventures.

"Music"

"Find Us Here"